Lidocaine 2% jelly versus lidocaine 2%-sodium hyaluronate 0.3% drops in phacoemulsification surgery.
Chatziralli
Irini P
IP
Papazisis
Leonidas
L
Sergentanis
Theodoros N
TN
D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects; D003229:Conjunctival Diseases / Q000139:chemically induced; D004338:Drug Combinations; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D006940:Hyperemia / Q000139:chemically induced; D019654:Lens Implantation, Intraocular; D008012:Lidocaine / Q000008:administration & dosage* / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D010147:Pain Measurement; D010577:Petrolatum; D018918:Phacoemulsification
D000779:Anesthetics, Local; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D010577:Petrolatum; D006820:Hyaluronic Acid; D008012:Lidocaine